Fennec Pharmaceuticals

Fennec Pharmaceuticals is a small stage biotechnology company focused on the development of PEDMARKTM (a unique formulation of Sodium Thiosulfate) for the prevention of ototoxicity from cisplatin in pediatric patients.

Fennec Pharmaceuticals is a small stage biotechnology company focused on the development of PEDMARKTM (a unique formulation of Sodium Thiosulfate) for the prevention of ototoxicity from cisplatin in pediatric patients.